Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, Gland Pharma has informed that it enclosed details on Analyst/ Institutional Investor Meetings with the Company scheduled on 26th October 2021 and 27th October 2021.
The above information is a part of company’s filings submitted to BSE.